新型冠状病毒肺炎早期检测指标的危重症预警价值分析

王艳燕; 黄晶; 张德桂; 孔艳华; 朱德发; 王艳燕; 黄晶; 张德桂; 孔艳华; 朱德发

doi:10.13898/j.cnki.issn.1000-2200.2021.10.007

[1]

WU F, ZHAO S, YU B, et al. A new coronavirus associated with human respiratory diseasein China[J]. Nature, 2020, 579(7798): 265. doi: 10.1038/s41586-020-2008-3

[2]

CHEN N, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020(395): 507.

[3]

中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2): 145.

[4]

GUAN WJ, NI ZY, HU Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020, 382(18): 1708.

[5]

李殿明, 刘佳苗, 刘佳慧, 等. 普通型向重型演变的新型冠状病毒肺炎病人的危险因素分析[J]. 蚌埠医学院学报, 2020, 45(4): 421.

[6]

CARRASCO-SANCHEZ FJ, LOPEZ-CARMONA MD, MARTINEZ-MARCOS FJ, et al. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry[J]. Ann Med, 2021, 53(1): 103.

[7]

ALAHMAD B, AL-SHAMMARI AA, BENNAKHI A, et al. Fasting blood glucose and COVID-19 severity: nonlinearity matters[J]. Diabetes Care, 2020, 43(12): 3113. doi: 10.2337/dc20-1941

[8]

WANG S, MA P, ZHANG S, et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study[J]. Diabetologia, 2020, 63(10): 2102. doi: 10.1007/s00125-020-05209-1